Suzuki, Fumitaka <br/><br/>
Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Feb 2011 
 - 415-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.24058  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anemia--chemically induced<br/>Antiviral Agents--therapeutic use<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hemoglobins--metabolism<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Japan<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Oligopeptides--therapeutic use<br/>Polyethylene Glycols--therapeutic use<br/>Polymorphism, Single Nucleotide--genetics<br/>Pyrophosphatases--genetics<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Ribavirin--adverse effects